Icosavax, Inc.

ICVX · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$59$279$13$23
Short-Term Investments$159$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5$6$1$0
Total Curr. Assets$224$287$16$23
Property Plant & Equip (Net)$15$1$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets-$15-$1-$0$0
Total NC Assets$15$1$0$0
Other Assets$0$0$0$0
Total Assets$239$288$16$23
Liabilities
Payables$3$4$2$1
Short-Term Debt$2$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$1$2$0
Other Curr. Liab.$9$5$1$0
Total Curr. Liab.$14$9$6$1
LT Debt$7$0$5$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$32$30
Total NC Liab.$7$0$37$30
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$21$9$43$32
Equity
Pref Stock$0$288$30$0
Common Stock$0$0$0$0
Retained Earnings-$186-$94-$27-$8
AOCI-$0-$288$0$0
Other Equity$404$372-$30-$30
Total Equity$218$278-$27-$8
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$239$288$16$23
Net Debt-$50-$279-$8-$23